A carregar...

UCHL1 is a biomarker of aggressive multiple myeloma required for disease progression

The success of proteasome inhibition in multiple myeloma highlights the critical role for the ubiquitin-proteasome system (UPS) in this disease. However, there has been little progress in finding more specific targets within the UPS involved in myeloma pathogenesis. We previously found the ubiquitin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Hussain, Sajjad, Bedekovics, Tibor, Chesi, Marta, Bergsagel, P. Leif, Galardy, Paul J.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4747363/
https://ncbi.nlm.nih.gov/pubmed/26513019
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!